Viemed authorizes share repurchase of up to 1.98M shares (~5% of outstanding) through June 2026

VIEMED HEALTHCARE, INC.

Board authorized repurchase of up to 1,976,441 common shares (approx. 5% of outstanding) through June 2026.
Company has no net debt and full $55M credit facility available to fund repurchases and growth.
CEO cited strong Q1 2025 results, increased 2025 guidance, and disciplined capital allocation.
Acquisition of Lehan's Medical expected to close in Q3 2025; company repurchased ~2.6M shares since listing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.